Antibiotic Resistance of Gram Negatives isolates from loggerhead sea turtles (Caretta caretta) in the central Mediterranean Sea

Dipartimento di Sanità Pubblica Veterinaria, Università degli Studi di Messina, Polo Universitario SS Annunziata, 98167 Messina, Italy.
Marine Pollution Bulletin (Impact Factor: 2.79). 06/2009; 58(9):1363-6. DOI: 10.1016/j.marpolbul.2009.04.020
Source: PubMed

ABSTRACT Previous studies on fish and marine mammals support the hypothesis that marine species harbor antibiotic resistance and therefore may serve as reservoirs for antibiotic-resistance genetic determinants. The aim of this study was to assess the resistance to antimicrobial agents of Gram negative strains isolated from loggerhead sea turtles (Carettacaretta). Oral and cloacal swabs from 19 live-stranded loggerhead sea turtles, with hooks fixed into the gut, were analyzed. The antimicrobial resistance of the isolates to 31 antibiotics was assessed using the disk-diffusion method. Conventional biochemical tests identified Citrobacter spp., Proteus spp., Enterobacter spp., Escherichia spp., Providencia spp., Morganella spp., Pantoea spp., Pseudomonas spp. and Shewanella spp. Highest prevalences of resistance was detected to carbenicillin (100%), cephalothin (92.6%), oxytetracycline (81.3%) and amoxicillin (77.8%). The isolates showing resistance to the widest range of antibiotics were identified as Citrobacterfreundii, Proteusvulgaris, Providenciarettgeri and Pseudomonasaeruginosa. In this study, antibiotic resistant bacteria reflect marine contamination by polluted effluents and C.caretta is considered a bioindicator which can be used as a monitor for pollution.

Download full-text


Available from: Teresa Bottari, Jun 29, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of antibiotic resistance and the implicated mechanisms of resistance were evaluated in Enterococcus spp. and Escherichia coli, isolated from a total of 250 faecal samples of echinoderms collected from Azorean waters (Portugal). A total of 144 enterococci (120 Enterococcus faecium, 14 E. hirae, 8 E. faecalis, 2 E. gallinarum) and 10 E. coli were recovered. High percentages of resistance in enterococci were found for erythromycin, ampicillin, tetracyclin and ciprofloxacin. The erm(A) or erm(B), tet(M) and/or tet(L), vat(D), aac(6')-aph(2″) and aph(3')-IIIa genes were found in isolates resistant to erythromycin, tetracycline, quinupristin/dalfopristin, high-level gentamicin and high-level kanamycin, respectively. Resistance in E. coli isolates was detected for streptomycin, amikacin, tetracycline and tobramycin. The aadA gene was found in streptomycin-resistant isolates and tet(A)+tet(B) genes in tetracycline-resistant isolates. The data recovered are essential to improve knowledge about the dissemination of resistant strains through marine ecosystems and the possible implications involved in transferring these resistances either to other animals or to humans.
    Marine Pollution Bulletin 02/2013; 69(1-2). DOI:10.1016/j.marpolbul.2013.01.017 · 2.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: One of the mistakes for a company is to use the wrong set of performance measures for managing and evaluating its value-chain activities while aiming to gain a competitive advantage with a predetermined strategy. The losses due to this mistake may increase under the market conditions of increased uncertainty and rapid change. This study reviews the link between the competitive strategy, production and operations management and performance measures, and proposes the strategic performance modeling and measurement index (SPMMI) for agile competitors as a tool to effectively manage their value-chain activities
    Management of Engineering and Technology, 1999. Technology and Innovation Management. PICMET '99. Portland International Conference on; 02/1999
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: People with schizophrenia may be at increased risk for Type II diabetes because of the side effects of antipsychotic medication, poorer overall physical health, less healthy lifestyles, and poorer health care. The present study uses data bases collected by the Schizophrenia Patient Outcomes Research Team (PORT) to assess the prevalence and demographic and clinical correlates of diabetes within large populations of persons receiving treatment for schizophrenia. In the Schizophrenia PORT, Medicaid and Medicare data from 1991 and more recent interview data were collected regarding the comorbidity of schizophrenia and diabetes: prevalence, quality of life, physical health, and services utilization and costs. The study found that rates of diagnosed diabetes exceeded general population statistics well before the widespread use of the new antipsychotic drugs. Risk factors for diabetes were similar to those observed in the general population. The linkage of diabetes to poor physical health, medical morbidity, and increased service use and cost requires attention. This study of diabetes in the early 1990s suggests that even before the widespread use of the atypical antipsychotic drugs, diabetes was a major problem for persons with schizophrenia.
    Schizophrenia Bulletin 02/2000; 26(4):903-12. DOI:10.1093/oxfordjournals.schbul.a033504 · 8.61 Impact Factor